It was not investigated that whether the LMCD1-AS1/miR-526-3p/OSBPL5 axis has an effect on drug resistance in NSCLC in the present study; more studies are needed in the future for a better understanding of OSBPL5 role in NSCLC. This evidence concerns the gene LMCD1 and non-small cell lung carcinoma.